These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 39408958

  • 1. Soluble Epoxide Hydrolase Inhibition Attenuates Proteinuria by Alleviating Renal Inflammation and Podocyte Injuries in Adriamycin-Induced Nephropathy.
    Niu Q, Guo Z, Liang Y, Zuo L.
    Int J Mol Sci; 2024 Oct 02; 25(19):. PubMed ID: 39408958
    [Abstract] [Full Text] [Related]

  • 2. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
    Liang Y, Jing Z, Deng H, Li Z, Zhuang Z, Wang S, Wang Y.
    Biochem Biophys Res Commun; 2024 Oct 02; 463(1-2):70-5. PubMed ID: 25986738
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage.
    Wang Q, Pang W, Cui Z, Shi J, Liu Y, Liu B, Zhou Y, Guan Y, Hammock BD, Wang Y, Zhu Y.
    Am J Physiol Renal Physiol; 2013 Jan 15; 304(2):F168-76. PubMed ID: 23152298
    [Abstract] [Full Text] [Related]

  • 4. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.
    Bettaieb A, Koike S, Chahed S, Zhao Y, Bachaalany S, Hashoush N, Graham J, Fatima H, Havel PJ, Gruzdev A, Zeldin DC, Hammock BD, Haj FG.
    FEBS J; 2017 Jul 15; 284(13):1970-1986. PubMed ID: 28485854
    [Abstract] [Full Text] [Related]

  • 5. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
    Yamashita M, Yoshida T, Suzuki S, Homma K, Hayashi M.
    Clin Exp Nephrol; 2017 Feb 15; 21(1):16-26. PubMed ID: 27089875
    [Abstract] [Full Text] [Related]

  • 6. Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.
    Olearczyk JJ, Quigley JE, Mitchell BC, Yamamoto T, Kim IH, Newman JW, Luria A, Hammock BD, Imig JD.
    Clin Sci (Lond); 2009 Jan 15; 116(1):61-70. PubMed ID: 18459944
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation.
    Zhang X, Qu X, Sun YB, Caruana G, Bertram JF, Nikolic-Paterson DJ, Li J.
    PLoS One; 2013 Jan 15; 8(6):e67471. PubMed ID: 23840712
    [Abstract] [Full Text] [Related]

  • 11. Attenuation of glomerular filtration barrier damage in adriamycin-induced nephropathic rats with bufalin: an antiproteinuric agent.
    Zheng J, Gong J, Zhang A, Li S, Zeng Z, Han Y, Gan W.
    J Steroid Biochem Mol Biol; 2012 Apr 15; 129(3-5):107-14. PubMed ID: 22207085
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
    Guan N, Ren YL, Liu XY, Zhang Y, Pei P, Zhu SN, Fan Q.
    Nephrol Dial Transplant; 2015 Jun 15; 30(6):957-69. PubMed ID: 25646018
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S.
    Nephrol Dial Transplant; 2009 May 15; 24(5):1397-406. PubMed ID: 19042927
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
    Katary MM, Pye C, Elmarakby AA.
    Prostaglandins Other Lipid Mediat; 2017 Sep 15; 132():3-11. PubMed ID: 27596333
    [Abstract] [Full Text] [Related]

  • 20. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
    Imig JD, Zhao X, Zaharis CZ, Olearczyk JJ, Pollock DM, Newman JW, Kim IH, Watanabe T, Hammock BD.
    Hypertension; 2005 Oct 15; 46(4):975-81. PubMed ID: 16157792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.